Risk factors for deep venous thrombosis of the upper extremities

Annals of Internal Medicine

Volumn 126, Issue 9, 1997, Pages 707-711

  Martinelli, Ida ^a,b   Cattaneo, Marco ^a,b   Panzeri, Daniela ^a,b   Taioli, Emanuela ^a   Mannucci, Pier Mannuccio ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOLIPID ANTIBODY;

ADULT; ARM; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; EXERCISE; FEMALE; HUMAN; HYPERCOAGULABILITY; HYPERHOMOCYSTEINEMIA; LEG; MALE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0030932968     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-126-9-199705010-00006     Document Type: Article

References (20)

1. Rochester JR, Beard JD. Acute management of subclavian vein thrombosis. Br J Surg. 1995;82:433-4.
2. Bernardi E, Cogo A, Prandoni P, Polistena P, Verlato F, Angelini F, et al. Upper extremity deep vein thrombosis: acquired risk factors, diagnosis, and acute embolic complications. In: Deep Vein Thrombosis: Risk Factors, Diagnosis, and Clinical Course. Cogo A, PhD Thesis. Padova: Editgraf; 1995:191-206.
3. Horattas MC, Wright DJ, Fenton AH, Evans DM, Oddi MA, Kamienski RW, et al. Changing concepts of deep venous thrombosis of the upper extremity. Report of a series and review of the literature. Surgery. 1988;104:561-7.
4. Prescott SM, Tikoff G. Deep venous thrombosis of the upper extremity: a reappraisal. Circulation. 1979;59:350-5.
5. Demeter SL, Pritchard JS, Piedad OH, Cordasco EM, Taherj S. Upper extremity thrombosis: etiology and prognosis. Angiology. 1982;33:743-8.
6. Thomas D. Pathogenesis of venous thrombosis. In: Bloom AL, Forbes CD, Thomas DP, Tuddenham EG, eds. Haemostasis and Thrombosis. 3d ed. Edinburgh: Churchill Livingstone; 1994:1335-47.
7. De Stefano V, Finazzi G, Mannucci PM. Inherited thrombophilia: pathogenesis, clinical syndromes, and management. Blood. 1996;87:3531-44.
8. Aziz S, Straehley O, Whelan TJ. Effort-related axillosubclavian vein thrombosis. A new theory of pathogenesis and a plea for direct surgical intervention. Am J Surg. 1986;152:57-60.
9. Donayre CE, White GH, Mehringer SM, Wilson SE. Pathogenesis determines late morbidity of axillosubclavian vein thrombosis. Am J Surg. 1986;152:179-84.
10. AbuRahma AF, Sadler D, Stuart P, Khan MZ, Boland JP. Conventional versus thrombolytic therapy in spontaneous (effort) axillary-subclavian vein thrombosis. Am J Surg. 1991;161:459-65.
11. Frezzato M, Tosetto A, Rodeghiero F. Validated questionnaire for the identification of previous personal or familial venous thromboembolism. Am J Epidemiol. 1996;143:1257-65.
12. Faioni EM, Franchi F, Asti D, Sacchi E, Bernardi F, Mannucci PM. Resistance to activated protein C in nine thrombophilic families: interference with a protein S assay. Thromb Haemost. 1993;70:1067-71.
13. de Ronde H, Bertina RM. Laboratory diagnosis of APC resistance: a critical evaluation of the test and the development of diagnostic criteria. Thromb Haemost. 1994;72:880-6.
14. Martinelli I, Landi G, Merati G, Cella R, Tosetto A, Mannucci PM. Factor V gene mutation is a risk factor for cerebral venous thrombosis. Thromb Haemost. 1996;75:393-4.
15. Malinow MR, Kang SS, Taylor LM, Wong PW, Coull B, Inahara T, et al. Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease. Circulation. 1989;79:1180-8.
16. Malinow MR. Homocyst(e)ine and arterial occlusive disease. J Intern Med. 1994;236:603-17.
17. Dahlbäck B. Inherited thrombophilia: resistance to activated protein C as a pathogenic factor of venous thromboembolism. Blood. 1995;85:607-14.
18. Koster T, Rosendaal FR, de Ronde H, Briët E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet. 1993;342:1503-6.
19. Falcon CR, Cattaneo M, Panzeri D, Martinelli I, Mannucci PM. High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis. Arterioscler Thromb. 1994;14:1080-3.
20. den Heijer M, Blom HJ, Gerrits WB, Rosendaal FR, Haak HL, Wijermans PW, et al. Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis? Lancet. 1995;345:882-5.